Advertisement

Research Article Free access | 10.1172/JCI115780

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

P Nuutila, V A Koivisto, J Knuuti, U Ruotsalainen, M Teräs, M Haaparanta, J Bergman, O Solin, L M Voipio-Pulkki, and U Wegelius

Department of Medicine, University of Turku, Finland.

Find articles by Nuutila, P. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Koivisto, V. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Knuuti, J. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Ruotsalainen, U. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Teräs, M. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Haaparanta, M. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Bergman, J. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Solin, O. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Voipio-Pulkki, L. in: PubMed | Google Scholar

Department of Medicine, University of Turku, Finland.

Find articles by Wegelius, U. in: PubMed | Google Scholar

Published June 1, 1992 - More info

Published in Volume 89, Issue 6 on June 1, 1992
J Clin Invest. 1992;89(6):1767–1774. https://doi.org/10.1172/JCI115780.
© 1992 The American Society for Clinical Investigation
Published June 1, 1992 - Version history
View PDF
Abstract

Positron emission tomography permits noninvasive measurement of regional glucose uptake in vivo in humans. We employed this technique to determine the effect of FFA on glucose uptake in leg, arm, and heart muscles. Six normal men were studied twice under euglycemic hyperinsulinemic (serum insulin approximately 500 pmol/liter) conditions, once during elevation of serum FFA by infusions of heparin and Intralipid (serum FFA 2.0 +/- 0.4 mmol/liter), and once during infusion of saline (serum FFA 0.1 +/- 0.01 mmol/liter). Regional glucose uptake rates were measured using positron emission tomography-derived 18F-fluoro-2-deoxy-D-glucose kinetics and the three-compartment model described by Sokoloff (Sokoloff, L., M. Reivich, C. Kennedy, M. C. Des Rosiers, C. S. Patlak, K. D. Pettigrew, O. Sakurada, and M. Shinohara. 1977. J. Neurochem. 28: 897-916). Elevation of plasma FFA decreased whole body glucose uptake by 31 +/- 2% (1,960 +/- 130 vs. 2,860 +/- 250 mumol/min, P less than 0.01, FFA vs. saline study). This decrease was due to inhibition of glucose uptake in the heart by 30 +/- 8% (150 +/- 33 vs. 200 +/- 28 mumol/min, P less than 0.02), and in skeletal muscles; both when measured in femoral (1,594 +/- 261 vs. 2,272 +/- 328 mumol/min, 25 +/- 13%) and arm muscles (1,617 +/- 411 to 2,305 +/- 517 mumol/min, P less than 0.02, 31 +/- 6%). Whole body glucose uptake correlated with glucose uptake in femoral (r = 0.75, P less than 0.005), and arm muscles (r = 0.69, P less than 0.05) but not with glucose uptake in the heart (r = 0.04, NS). These data demonstrate that the glucose-FFA cycle operates in vivo in both heart and skeletal muscles in humans.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (June 1, 1992): No description
Advertisement
Advertisement